Michael Sinclair

This profile gathers the share dealings of Michael Sinclair in Opiant Pharmaceuticals, Inc., where the filings describe the role as board member. We count 6 filings; the first trade dates from 23 August 2021 and the latest from 2 March 2023.

On the market, this insider has only sold: 4 sales, €368k in total. The rest of the record consists of 1 option exercise.

On 3 March 2023 came the latest disclosure, a transaction for €515k in Opiant Pharmaceuticals, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.